For citations:
Enaldieva D.A., Krivorotko P.V., Imyanitov E.N., Zhiltsova E.K., Donskikh R.V., Sokolenko A.P., Shaykhelislamova L.F., Tabagua T.T., Gigolaeva L.P., Komyakhov A.V., Nikolaev K.S., Zernov K.Yu., Ereshchenko S.S., Paltuev R.M., Bessonov A.A., Artemyeva A.S., Pesotskiy R.S., Amirov N.S., Emelyanov A.S., Mortada V.V., Bondarchuk Ya.I., Semiglazov V.V., Semiglazova T.Yu., Semiglazov V.F., Belyaev A.M. The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience. Tumors of female reproductive system. 2023;19(1):48-55. (In Russ.) https://doi.org/10.17650/1994-4098-2023-19-1-48-55
Email this article 